PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 28, 2025Pulmonary Therapy5 citationsOpen Access

Dyspnea in Chronic Obstructive Pulmonary Disease: Expert Assessment of Management in Clinical Practice

View Full Paper
NPNirupama PutchaDMDiego J. MaselliJBJessica Bon

Key Points

  • Dyspnea significantly impacts the quality of life in COPD patients, especially during exacerbations.
  • Effective communication between patients and healthcare practitioners is essential for proper management of dyspnea.
  • Current guidelines include treatment strategies for dyspnea, yet patients often lack understanding of their condition.
  • Practical management recommendations for dyspnea include identifying underlying causes and implementing both pharmacologic and nonpharmacologic strategies.

Abstract

Chronic obstructive pulmonary disease (COPD) is a multifaceted lung condition characterized by persistent airflow limitation that leads to chronic symptoms, including dyspnea, cough, and exacerbations. To date, a major focus for the assessment and management of COPD has been on mitigating exacerbations. However, dyspnea is the most common symptom of COPD and is responsible for substantial negative effects on patients' quality of life. Dyspnea is also a substantial contributor to the symptoms associated with acute exacerbations in COPD. Though a portion of the current recommendations for the assessment and management of COPD are dedicated to dyspnea treatment intervention strategies, there remains a need for improvement in communication between healthcare practitioners and their patients regarding the understanding of dyspnea and the implementation of key nonpharmacologic and pharmacologic treatment options. This clinical commentary outlines practical considerations and recommendations for the real-world assessment and management of dyspnea in COPD, including underlying causes, patient and healthcare provider dialogue, measurement of severity, and management strategies. Chronic obstructive pulmonary disease, or COPD, is a long-term disease of the lungs that can cause several symptoms, including cough, flare-ups (times when symptoms suddenly worsen, also known as exacerbations), and breathlessness (also referred to as dyspnea). Medications and other therapies for COPD mainly focus on reducing how often exacerbations happen or how bad they are. However, dyspnea is a major problem for patients with COPD, often making it difficult to live their everyday lives. Moreover, dyspnea is commonly seen in patients with COPD when they have an exacerbation. Although current recommendations for the management of COPD include strategies to help with dyspnea, patients may still need more information about their dyspnea and how to manage it. This could be due to several factors, including a disconnect in the dialogue patients have with their doctors regarding their experience of dyspnea. This article shares practical insights from respiratory doctors on how they help patients with COPD manage their dyspnea and provides an overview of the causes, measurement, and management of dyspnea.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Putcha et al. (2025) studied this question.

synapsesocial.com/papers/68d90a0141e1c178a14f5fbahttps://doi.org/10.1007/s41030-025-00318-x
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease2023 · 123 citations
  2. 2E-cigarette Use and Incident Cardiometabolic Conditions in the All of Us Research Program2025 · 29 citations
  3. 3The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis2023 · 9 citations
  4. 4E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials2022 · 97 citations
  5. 5Oxygen Therapy in COPD2023 · 18 citations